10x Genomics, Inc. (NASDAQ:TXG) Q1 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to the 10x Genomics’ First Quarter 2023 Earnings Conference Call. My name is Bruno, and I will be the operator of today.
10X Genomics Inc. (TXG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 4,155,323 | $231,825,470 | -4% | 1.59% |
| 2. | SRS Investment Management Karthik Sarma | 3,005,427 | $167,672,772 | 2.4% | |
| 3. | Generation Investment Management David Blood And Al Gore | 2,519,373 | $140,555,820 | -2% | 0.74% |
| 4. | Citadel Investment Group Ken Griffin | 1,230,127 | $68,628,785 | -16% | 0.01% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 676,861 | $37,762,075 | 0.09% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.49 | 158 | Officer | 60,046 | 2022-05-13 | Filing | |
| $40.49 | 158 | Officer | 97,523 | 2022-05-13 | Filing | |
| $39.00 | 300,000 | Director | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 300,000 | Director | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 187,500 | Large Shareholder | 187,500 | 2019-09-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.06 | 791 | 284,236 | 2023-05-23 | Filing | ||
| $55.06 | 735 | 285,027 | 2023-05-23 | Filing | ||
| $55.06 | 619 | 285,762 | 2023-05-23 | Filing | ||
| $55.06 | 243 | 286,381 | 2023-05-23 | Filing | ||
| $55.07 | 316 | 110,952 | 2023-05-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 10,520,691 | $586,949,429 | 0.06% | |
| 2. | 8,783,621 | $490,038,215 | 0.01% | |
| 3. | 8,753,987 | $488,384,935 | 0.45% | |
| 4. | 5,239,107 | $292,289,781 | 0% | |
| 5. | 4,372,294 | $243,930,306 | 0.02% |
News See All
10x Genomics, Inc. (NASDAQ:TXG) Q4 2022 Earnings Call Transcript
Operator: Good afternoon. Thank you for attending today's 10x Genomics Fourth Quarter and Full Year 2022 Earnings Conference Call. My name is Bethany, and I will be the moderator for today's call.
4 Cheap Stocks to Buy According to Cathie Wood
ARK increased its holding in Twist Bioscience by 7% in the third quarter of this year, ending the period with 6.8 million shares of the company, worth $235.3 million.
Here's Why 10x Genomics (TXG) Underperformed in the Third Quarter
Baron Funds, an asset management company, released its “Baron Global Advantage Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
12 Biggest Genomics Companies In The World
In this article, we will discuss the 12 Biggest Genomics Companies In The World.
Harvard University's Latest Portfolio: 10 Best Biotech Stock Picks
In this article, we will look at Harvard University's latest stock portfolio and list its 10 best biotech stock picks.
10 Cathie Wood Stocks to Buy Before the Bull Run Starts
In this article, we discuss 10 Cathie Wood stocks to buy before the bull run starts.
Cathie Wood's Top 10 Buys in July
In the beginning of July, Cathie Wood of ARK Investment Management admitted that while her predictions about inflation were wrong, the US seems to be heading towards a deflationary environment.
This Billionaire Hedge Fund Manager Just Sold Off Shopify Inc (SHOP) and 4 Other Stocks
Below we look at why This Billionaire Hedge Fund Manager Just Sold Off Shopify Inc (SHOP) and 4 Other Stocks.
Billionaire Ken Griffin is Selling These 10 Stocks in 2022
In this article, we discuss the 10 stocks billionaire Ken Griffin is selling in 2022.
Billionaire Hedge Funds
